Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis

Overview

Journal Chest

Publisher Elsevier

Specialty Pulmonary Medicine

Date 2021 Oct 21

PMID 34673022

Citations 48

Authors

Daniel O Thomas-Ruddel

Peter Schlattmann

Mathias Pletz

Oliver Kurzai

Frank Bloos

Affiliations

Soon will be listed here.

Abstract

Background: Current guidelines recommend empirical antifungal therapy in patients with sepsis with high risk of invasive Candida infection. However, many different risk factors have been derived from multiple studies. These risk factors lack specificity, and broad application would render most ICU patients eligible for empirical antifungal therapy.

Research Question: What risk factors for invasive Candida infection can be identified by a systematic review and meta-analysis?

Study Design And Methods: We searched PubMed, Web of Science, ScienceDirect, Biomed Central, and Cochrane and extracted the raw and adjusted OR for each risk factor associated with invasive Candida infection. We calculated pooled ORs for risk factors present in more than one study.

Results: We included 34 studies in our meta-analysis resulting in the assessment of 29 possible risk factors. Risk factors for invasive Candida infection included demographic factors, comorbid conditions, and medical interventions. Although demographic factors do not play a role for the development of invasive Candida infection, comorbid conditions (eg, HIV, Candida colonization) and medical interventions have a significant impact. The risk factors associated with the highest risk for invasive Candida infection were broad-spectrum antibiotics (OR, 5.6; 95% CI, 3.6-8.8), blood transfusion (OR, 4.9; 95% CI, 1.5-16.3), Candida colonization (OR, 4.7; 95% CI, 1.6-14.3), central venous catheter (OR, 4.7; 95% CI, 2.7-8.1), and total parenteral nutrition (OR, 4.6; 95% CI, 3.3-6.3). However, dependence between the various risk factors is probably high.

Interpretation: Our systematic review and meta-analysis identified patient- and treatment-related factors that were associated with the risk for the development of invasive Candida infection in the ICU. Most of the factors identified were either related to medical interventions during intensive care or to comorbid conditions.

Citing Articles

Epidemiology and risk factors of fungal pathogens in sepsis: a prospective nationwide multicenter cohort study.

Lee J, Kang D, Ju H, Oh D, Lee S, Park M BMC Infect Dis. 2025; 25(1):331.

PMID: 40065215 PMC: 11892223. DOI: 10.1186/s12879-025-10722-y.

Retinoids as Alternative Antifungal Agents Against : and Evidence.

Cosio T, Romeo A, Pistoia E, Pica F, Freni C, Iacovelli F Microorganisms. 2025; 13(2).

PMID: 40005604 PMC: 11857849. DOI: 10.3390/microorganisms13020237.

Establishment and Validation of a Machine-Learning Prediction Nomogram Based on Lymphocyte Subtyping for Intra-Abdominal Candidiasis in Septic Patients.

Zhang J, Cheng W, Li D, Zhao G, Lei X, Cui N Clin Transl Sci. 2025; 18(1):e70140.

PMID: 39835620 PMC: 11747989. DOI: 10.1111/cts.70140.

A Narrative Review of Invasive Candidiasis in the Intensive Care Unit.

Noppe E, Eloff J, Keane S, Martin-Loeches I Ther Adv Pulm Crit Care Med. 2025; 19:29768675241304684.

PMID: 39748830 PMC: 11693998. DOI: 10.1177/29768675241304684.

The (1,3)-β-D-glucan use for invasive candidiasis diagnosis in non-neutropenic critically ill patients: a prospective cohort study.

Tlili B, Trifi A, Kallel A, Mehdi A, Seghir E, Messaoued L Tunis Med. 2025; 102(12):1004-1008.

PMID: 39748684 PMC: 11770794. DOI: 10.62438/tunismed.v102i12.5254.

References

Ostrosky-Zeichner L, Sable C, Sobel J, Alexander B, Donowitz G, Kan V . Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007; 26(4):271-6. DOI: 10.1007/s10096-007-0270-z. View

Teoh F, Pavelka N . How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions. Pathogens. 2016; 5(1). PMC: 4810127. DOI: 10.3390/pathogens5010006. View

Pappas P, Kauffman C, Andes D, Clancy C, Marr K, Ostrosky-Zeichner L . Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2015; 62(4):e1-50. PMC: 4725385. DOI: 10.1093/cid/civ933. View

Irvine K, Ratnasekera I, Powell E, Hume D . Causes and Consequences of Innate Immune Dysfunction in Cirrhosis. Front Immunol. 2019; 10:293. PMC: 6401613. DOI: 10.3389/fimmu.2019.00293. View

Playford E, Lipman J, Jones M, Lau A, Kabir M, Chen S . Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients. Clin Infect Dis. 2016; 63(11):1463-1469. DOI: 10.1093/cid/ciw610. View

Kumamoto C . Inflammation and gastrointestinal Candida colonization. Curr Opin Microbiol. 2011; 14(4):386-91. PMC: 3163673. DOI: 10.1016/j.mib.2011.07.015. View

De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group.... Clin Infect Dis. 2008; 46(12):1813-21. PMC: 2671227. DOI: 10.1086/588660. View

Delaloye J, Calandra T . Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2013; 5(1):161-9. PMC: 3916370. DOI: 10.4161/viru.26187. View

Arslan F, Caskurlu H, Sari S, Dal H, Turan S, Erturk Sengel B . Risk factors for noncatheter-related Candida bloodstream infections in intensive care units: A multicenter case-control study. Med Mycol. 2018; 57(6):668-674. DOI: 10.1093/mmy/myy127. View

10.

Pratikaki M, Platsouka E, Sotiropoulou C, Douka E, Paramythiotou E, Kaltsas P . Epidemiology, risk factors for and outcome of candidaemia among non-neutropenic patients in a Greek intensive care unit. Mycoses. 2009; 54(2):154-61. DOI: 10.1111/j.1439-0507.2009.01787.x. View

11.

Rouze A, Loridant S, Poissy J, Dervaux B, Sendid B, Cornu M . Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial. Intensive Care Med. 2017; 43(11):1668-1677. DOI: 10.1007/s00134-017-4932-8. View

12.

Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E . Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med. 2017; 43(9):1225-1238. DOI: 10.1007/s00134-017-4731-2. View

13.

Papadimitriou-Olivgeris M, Spiliopoulou A, Fligou F, Spiliopoulou I, Tanaseskou L, Karpetas G . Risk factors and predictors of mortality of candidaemia among critically ill patients: role of antifungal prophylaxis in its development and in selection of non-albicans species. Infection. 2017; 45(5):651-657. DOI: 10.1007/s15010-017-1050-z. View

14.

Hotchkiss R, Monneret G, Payen D . Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013; 13(12):862-74. PMC: 4077177. DOI: 10.1038/nri3552. View

15.

Leon C, Ruiz-Santana S, Saavedra P, Galvan B, Blanco A, Castro C . Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009; 37(5):1624-33. DOI: 10.1097/CCM.0b013e31819daa14. View

16.

Paphitou N, Ostrosky-Zeichner L, Rex J . Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol. 2005; 43(3):235-43. DOI: 10.1080/13693780410001731619. View

17.

Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D . Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care. 2011; 15(6):R287. PMC: 3388661. DOI: 10.1186/cc10574. View

18.

Jorda-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, Leon M . Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses. 2007; 50(4):302-10. DOI: 10.1111/j.1439-0507.2007.01366.x. View

19.

Swindell K, Lattif A, Chandra J, Mukherjee P, Ghannoum M . Parenteral lipid emulsion induces germination of Candida albicans and increases biofilm formation on medical catheter surfaces. J Infect Dis. 2009; 200(3):473-80. DOI: 10.1086/600106. View

20.

Chander J, Singla N, Sidhu S, Gombar S . Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India. J Infect Dev Ctries. 2013; 7(9):670-5. DOI: 10.3855/jidc.2623. View